| For: | Thomassin L, Armengol-Debeir L, Charpentier C, Bridoux V, Koning E, Savoye G, Savoye-Collet C. Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease. World J Gastroenterol 2017; 23(23): 4285-4292 [PMID: 28694669 DOI: 10.3748/wjg.v23.i23.4285] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i23/4285.htm |
| Number | Citing Articles |
| 1 |
Mary-Louise C. Greer, Stuart A. Taylor. Perianal Imaging in Crohn Disease: Current Status With a Focus on MRI, From the AJR Special Series on Imaging of Inflammation. American Journal of Roentgenology 2022; 218(5) doi: 10.2214/AJR.21.26615
|
| 2 |
Giulio Aniello Santoro, Christian Raymond S. Magbojos, Giovanni Maconi, Iwona Sudoł-Szopińska. Pelvic Floor Disorders. 2021; doi: 10.1007/978-3-030-40862-6_81
|
| 3 |
Viviane Lin, Seyma Gögenur, Frederik Pachler, Tina Fransgaard, Ismail Gögenur. Risk Prediction for Complications in Inflammatory Bowel Disease Surgery: External Validation of the American College of Surgeons’ National Surgical Quality Improvement Program Surgical Risk Calculator. Journal of Crohn's and Colitis 2023; 17(1) doi: 10.1093/ecco-jcc/jjac114
|
| 4 |
Marion Chambaz, Mikael Verdalle-Cazes, Charlotte Desprez, Lucie Thomassin, Cloé Charpentier, Sébastien Grigioni, Laura Armengol-Debeir, Valérie Bridoux, Guillaume Savoye, Céline Savoye-Collet. Deep remission on magnetic resonance imaging impacts outcomes of perianal fistulizing Crohn’s disease. Digestive and Liver Disease 2019; 51(3) doi: 10.1016/j.dld.2018.12.010
|
| 5 |
Nicolas Richard, Antonin Derinck, Valérie Bridoux, Cloé Charpentier, Céline Savoye Collet, Guillaume Savoye. Which magnetic resonance imaging feature is associated with treatment response in perianal fistulizing Crohn’s disease?. Abdominal Radiology 2024; 49(8) doi: 10.1007/s00261-024-04238-3
|
| 6 |
Ye Ma, Runfeng Zhang, Wei Liu, Yinghao Sun, Jingnan Li, Hong Yang, Hong Lv, Yue Li, Bei Tan, Xiyu Sun, Jiaming Qian, Ji Li. Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s disease. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02676-9
|
| 7 |
Yi Fan Lin, Alicia Truchon, Boris Djoukam Mbuko, Huan Yu Lily Dai, Samuel Sassine, Amélie Damphousse, Sébastien Benali, Mona Beaunoyer, Colette Deslandres, Prévost Jantchou. Factors Associated with Fistulizing Crohn’s Disease in Children at Diagnosis: A Cross-Sectional Study. Inflammatory Bowel Diseases 2026; 32(2) doi: 10.1093/ibd/izaf220
|
| 8 |
Francesca Maccioni, Ludovica Busato, Lorenza Bottino, Alessandro Longhi, Alessandra Valenti, Maddalena Zippi, Carlo Catalano. Comprehensive Imaging Evaluation and Staging of Crohn’s Disease: When and Why to Use Intestinal Ultrasound, MRE, or CTE: Current Guidelines and Future Directions. Diagnostics 2026; 16(6) doi: 10.3390/diagnostics16060882
|
| 9 |
D. Cao, X. Wang, Y. Zhang, K. Qian, N. Yang, M. Zhu, Y. Li, G. Wu, Z. Cui. Total fistula volume predicts surgical outcomes in complex perianal fistulizing Crohn’s disease following fistula-tract laser closure: a single-center retrospective study. Techniques in Coloproctology 2025; 29(1) doi: 10.1007/s10151-024-03094-z
|
| 10 |
Bo-Lin Yang, Hong-Jin Chen, Li-Chao Qiao, Shan-Shan Tao, Shi-Yi Chen, Xue-Liang Sun. Optimized timing of using infliximab in perianal fistulizing Crohn's disease. World Journal of Gastroenterology 2020; 26(14): 1554-1563 doi: 10.3748/wjg.v26.i14.1554
|
| 11 |
David A. Schwartz, Laurent Peyrin-Biroulet, Karen Lasch, Shashi Adsul, Silvio Danese. Efficacy and Safety of 2 Vedolizumab Intravenous Regimens for Perianal Fistulizing Crohn’s Disease: ENTERPRISE Study. Clinical Gastroenterology and Hepatology 2022; 20(5) doi: 10.1016/j.cgh.2021.09.028
|
| 12 |
Xiaohan Yan, Mingming Zhu, Qi Feng, Yunqi Yan, Jiangchen Peng, Xitao Xu, Antao Xu, Zhihua Ran. Evaluating the effectiveness of infliximab on perianal fistulizing Crohn’s disease by magnetic resonance imaging. Gastroenterology Report 2019; 7(1) doi: 10.1093/gastro/goy036
|
| 13 |
Pankaj Garg, Vipul D. Yagnik, Baljit Kaur, Geetha R. Menon, Sushil Dawka. Role of MRI to confirm healing in complex high cryptoglandular anal fistulas: long‐term follow‐up of 151 cases. Colorectal Disease 2021; 23(9) doi: 10.1111/codi.15695
|
| 14 |
Tanya Lee, Eric Yong, Nik S Ding. Radiological outcomes in perianal fistulizing Crohn's disease: A systematic review and meta‐analysis. JGH Open 2020; 4(3) doi: 10.1002/jgh3.12295
|
| 15 |
Sudheer K Vuyyuru, Virginia Solitano, Siddharth Singh, Jurij Hanzel, John K Macdonald, Silvio Danese, Laurent Peyrin Biroulet, Christopher Ma, Vipul Jairath. Scoring Indices for Perianal Fistulising Crohn’s Disease: A Systematic Review. Journal of Crohn's and Colitis 2024; 18(6) doi: 10.1093/ecco-jcc/jjad214
|
| 16 |
Firas Rinawi, Mary-Louise C. Greer, Thomas Walters, Peter C. Church, Amanda Ricciuto, Jacob C. Langer, Anne M Griffiths. Anti TNF treatment of complex perianal fistulas in children without luminal Crohn's disease: Is it an option?. Journal of Pediatric Surgery 2022; 57(11) doi: 10.1016/j.jpedsurg.2022.03.031
|
| 17 |
UEG Week 2018 Poster Presentations. United European Gastroenterology Journal 2018; 6(S8) doi: 10.1177/2050640618792819
|
| 18 |
Arshdeep Singh, Chandan Kakkar, Shreya Garg, Kirti Arora, Vandana Midha, Ramit Mahajan, Satpal Singh Virk, Narender Pal Jain, Dharmatma Singh, Kriti Sood, Ashish Tripathi, Dhruv Gupta, Ishita Gupta Kaushal, Ritu Dhawan Galhotra, Kavita Saggar, Ajit Sood. Clinical and magnetic resonance imaging spectrum of complex perianal fistulizing Crohn’s disease: A cohort study from northern India. Indian Journal of Gastroenterology 2023; 42(5) doi: 10.1007/s12664-023-01399-9
|
| 19 |
Ashish R Srinivasan, Abhinav Vasudevan, Numan Kutaiba, Gauraang Bhatnagar, Isabelle De Kock, Lynna Chen, Habeeb Habeeb. Imaging in perianal fistulising Crohn’s disease: A practical guide for the gastroenterologist. World Journal of Gastroenterology 2025; 31(34): 110611 doi: 10.3748/wjg.v31.i34.110611
|
| 20 |
Nicola S. Fearnhead. Inflammatory Bowel Disease Nursing Manual. 2019; doi: 10.1007/978-3-319-75022-4_20
|
| 21 |
Parul Tandon, Glara Gaeun Rhee, David Schwartz, Jeffrey D. McCurdy. Strategies to Optimize Anti-tumor Necrosis Factor Therapy for Perianal Fistulizing Crohn’s Disease: A Systematic Review. Digestive Diseases and Sciences 2019; 64(11) doi: 10.1007/s10620-019-05635-1
|
| 22 |
C. Charpentier, M. Verdalle-Cazes, C. Savoye-Collet. Exploration en imagerie des fistules anales. EMC - Radiologie et imagerie médicale - Abdominale - Digestive 2025; 43(3) doi: 10.1016/S1879-8527(25)49549-5
|
| 23 |
Qi Chen, Lingbo Li, Can Wang, Lichao Qiao, Minna Wu, Weiming Zhu, Bolin Yang, Yuxia Gong. Durable clinical and deep remission with ustekinumab in perianal fistulizing Crohn’s disease: A 2-year retrospective real-world cohort study. Digestive and Liver Disease 2025; 57(11) doi: 10.1016/j.dld.2025.08.091
|
| 24 |
Tanya Lee, Michael A Kamm, Sally Bell, Mark Lust, Steve Brown, Ola Niewiadomski, Chamara Basnayake, Emily Wright, Basil D'Souza, Rodney Woods, Shu Chen Wei, William Connell, Alexander Thompson, Eric Yong, Nik Sheng Ding. Long‐term outcomes of perianal fistulizing Crohn's disease in the biologic era. JGH Open 2021; 5(2) doi: 10.1002/jgh3.12475
|
| 25 |
Laurent Abramowitz, Laurent Siproudhis, Xavier Roblin, Pedro Fernandez, Antoine Petitcollin, Marcelo De Carvalho Bittencourt, Sandrine Sironneau, Marine Peyneau, Pascale Roland Nicaise, Dominique Bouchard, Guillaume Bouguen, Camille Zallot, Nathalie Gault, Anne-Laure Pelletier, Laura Sirmai. Relationship between clinical remission of perianal fistulas in Crohn’s disease and serum adalimumab concentrations: A multi-center cross-sectional study. World Journal of Gastroenterology 2022; 28(9): 961-972 doi: 10.3748/wjg.v28.i9.961
|
| 26 |
Bénédicte Caron, Ferdinando D’Amico, Silvio Danese, Laurent Peyrin-Biroulet. Endpoints for Perianal Crohn’s Disease Trials: Past, Present and Future. Journal of Crohn's and Colitis 2021; 15(8) doi: 10.1093/ecco-jcc/jjab026
|
| 27 |
Jeffrey D. McCurdy, Javeria Munir, Simon Parlow, Jacqueline Reid, Russell Yanofsky, Talal Alenezi, Joseph Meserve, Brenda Becker, Zubin Lahijanian, Anas Hussam Eddin, Ranjeeta Mallick, Tim Ramsay, Greg Rosenfeld, Ali Bessissow, Talat Bessissow, Vipul Jairath, Siddharth Singh, David H. Bruining, Blair Macdonald. Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn’s Disease: A Multicenter Study. Clinical Gastroenterology and Hepatology 2024; 22(5) doi: 10.1016/j.cgh.2023.12.006
|
| 28 |
Etienne Buscail, Guillaume Le Cosquer, Fabian Gross, Marine Lebrin, Laetitia Bugarel, Céline Deraison, Nathalie Vergnolle, Barbara Bournet, Cyrielle Gilletta, Louis Buscail. Adipose-Derived Stem Cells in the Treatment of Perianal Fistulas in Crohn’s Disease: Rationale, Clinical Results and Perspectives. International Journal of Molecular Sciences 2021; 22(18) doi: 10.3390/ijms22189967
|
| 29 |
Fabian Juliao-Baños, Carlos Fernando Grillo A, Luis Fernando Pineda Ovalle, William Otero Regino. , María Teresa Galiano de Sánchez. , Rafael García Duperly. , María Teresa Vallejo O. , Marcela Torres Amaya. . Guía de práctica clínica para el tratamiento de la enfermedad de Crohn en población adulta . Revista Colombiana de Gastroenterología 2020; 35(Supl. 2) doi: 10.22516/25007440.637
|
| 30 |
Nadia Fathallah, Cosmin Cristea, Hélène Beaussier, Sonia Khirani, Vincent de Parades. Infliximab for Anoperineal Lesions in Crohn's Disease: Remission Appears to be Based on Rapid Combination Therapy at High Doses. Journal of Coloproctology 2022; 42(02) doi: 10.1055/s-0041-1739549
|
| 31 |
Yi Xu, Yi-Hong Fan, Jing-Jing Wang, Xue-Hui Qiao, Ke-Fang Jiang, Rong Huang, Wan-Ting Cao. Predictive value of blood concentration of biologics on endoscopic inactivity in inflammatory bowel disease: A systematic review. World Journal of Gastroenterology 2021; 27(9): 886-907 doi: 10.3748/wjg.v27.i9.886
|
| 32 |
Nahla Azzam, Othman Alharbi, Majid Almadi, Abdulrahman Aljebreen, Turki AlAmeel, Mohammed Alabbas, Salman Bahammam, Ahmed Bashmail, Yasser Alomar, Mahmoud Mosli. Predictors of long-term outcomes of radiologically defined perianal fistulizing Crohn’s disease treated with antitumor necrosis factor-alpha agents based on Parks’ classification. European Journal of Gastroenterology & Hepatology 2020; 32(2) doi: 10.1097/MEG.0000000000001634
|
| 33 |
Torsten Kucharzik, Jeroen Tielbeek, Dan Carter, Stuart A Taylor, Damian Tolan, Rune Wilkens, Robert V Bryant, Christine Hoeffel, Isabelle De Kock, Christian Maaser, Giovanni Maconi, Kerri Novak, Søren R Rafaelsen, Martina Scharitzer, Antonino Spinelli, Jordi Rimola. ECCO-ESGAR Topical Review on Optimizing Reporting for Cross-Sectional Imaging in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2022; 16(4) doi: 10.1093/ecco-jcc/jjab180
|
| 34 |
Adam S Cheifetz, Konstantinos Papamichael. Defining and predicting deep remission in patients with perianal fistulizing Crohn’s disease on anti-tumor necrosis factor therapy. World Journal of Gastroenterology 2017; 23(34): 6197-6200 doi: 10.3748/wjg.v23.i34.6197
|
| 35 |
Jong Lyul Lee, Yong Sik Yoon, Chang Sik Yu. Treatment Strategy for Perianal Fistulas in Crohn Disease Patients: The Surgeon’s Point of View. Annals of Coloproctology 2021; 37(1) doi: 10.3393/ac.2021.02.08
|
| 36 |
Shi-Si Ding, Chang Liu, Guan-Qun Zhang, Wei-Wei Ren, Hui Zhao, Qian Zhang, Hao-Qiang Yin, Li-Ping Sun, Hui-Xiong Xu. Development and validation of a predictive model for early failure of biological therapy in perianal fistulizing Crohn’s disease based on three-dimensional transrectal ultrasound. Inflammatory Bowel Diseases 2026; doi: 10.1093/ibd/izag048
|